CHEBI:229526 - sparsentan

ChEBI IDCHEBI:229526
ChEBI Namesparsentan
Stars
DefinitionA biphenyl that is 1,1'-biphenyl substituted by (4,5-dimethyl-1,2-oxazol-3-yl)aminosulfonyl, ethoxymethyl, and (2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl groups at positions 2, 2' and 4', respectively. It is a dual antagonist of endothelin and angiotensin II receptors approved for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression.
Last Modified16 April 2024
SubmitterAdnan
DownloadsMolfile
FormulaC32H40N4O5S
Net Charge0
Average Mass592.762
Monoisotopic Mass592.27194
SMILESCCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1
InChIInChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)
InChIKeyWRFHGDPIDHPWIQ-UHFFFAOYSA-N
Wikipedia
Roles Classification
Biological Roles:
angiotensin receptor antagonist  A hormone antagonist that blocks angiotensin receptors.
endothelin A receptor antagonist  A endothelin receptor antagonist is a drug which selectively blocks endothelin A receptors.
Applications:
angiotensin receptor antagonist  A hormone antagonist that blocks angiotensin receptors.
endothelin A receptor antagonist  A endothelin receptor antagonist is a drug which selectively blocks endothelin A receptors.
nephroprotective agent  Any protective agent that is able to prevent damage to the kidney.
antihypertensive agent  Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
ChEBI Ontology
Outgoing Relation(s)
sparsentan (CHEBI:229526) has role angiotensin receptor antagonist (CHEBI:61016)
sparsentan (CHEBI:229526) has role antihypertensive agent (CHEBI:35674)
sparsentan (CHEBI:229526) has role endothelin A receptor antagonist (CHEBI:51452)
sparsentan (CHEBI:229526) has role nephroprotective agent (CHEBI:76595)
sparsentan (CHEBI:229526) is a azaspiro compound (CHEBI:35624)
sparsentan (CHEBI:229526) is a benzyl ether (CHEBI:59859)
sparsentan (CHEBI:229526) is a biphenyls (CHEBI:22888)
sparsentan (CHEBI:229526) is a isoxazoles (CHEBI:55373)
sparsentan (CHEBI:229526) is a sulfonamide (CHEBI:35358)
IUPAC Name 
4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-2'-(ethoxymethyl)[biphenyl]-2-sulfonamide
INNs  Source
sparsentanWHO MedNet
esparsentánWHO MedNet
sparsentanumWHO MedNet
sparsentanWHO MedNet
Synonyms  Source
PS-433540DrugBank
PS433540DrugBank
PS 433540ChEBI
RE-021DrugBank
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamideChEBI
Brand Name  Source
FilspariKEGG DRUG
Manual XrefsDatabases
DB12548DrugBank
D11776KEGG DRUG
SparsentanWikipedia
Citations